Comparative efficacy of high and low dose of interferon alfa-2b in chronic hepatitis C: A randomized controlled trial NC Tassopoulos*, G Karvountzis**. G Touloumi***, J Delladetsima****, GV Papatheodoridis*, A Katsoulidou***, G Retalis****, A Hatzakis***. *First Dept. of Medicine, Western Attica General Hospital, Athens, **State Dept. of Medicine, Hippokration General Hospital, Athens, ***Dept. of Hygiene and Epidemiology, Athens University Medical School, Athens, ****Laboratory of Pathology, Laikon General Hospital, Athens, *****Schering-Plough, Athens, Greece

Chronic Hepatitis ◽

Hepatitis C ◽

Medical School ◽

General Hospital ◽

Low Dose ◽

Controlled Trial ◽

Interferon Alfa ◽

Comparative Efficacy ◽

Sequential versus concomitant administration of ribavirin and interferon alfa-N3 in patients with chronic hepatitis C not responding to interferon alone. Results of a randomized controlled trial

Gastroenterology ◽

10.1016/s0016-5085(98)85458-9 ◽

1998 ◽

Vol 114 ◽

pp. A1344

Author(s):

Raffaello Sostegni ◽

Valeria Ghisetti ◽

Fabrizia Pittaluga ◽

Giovanna Marchiaro ◽

Giuseppe Rocca ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Trial ◽

Concomitant Administration ◽

Interferon Alfa ◽

Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: Results of an international randomized controlled trial

Hepatology ◽

10.1002/hep.510270429 ◽

1998 ◽

Vol 27 (4) ◽

pp. 1121-1127 ◽

Cited By ~ 44

Author(s):

Geoffrey C. Farrell ◽

Bruce R. Bacon ◽

Robert D. Goldin ◽

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Controlled Trial ◽

Interferon Alfa ◽

Recombinant Interferon ◽

Randomized Controlled ◽

Term Response ◽

Lymphoblastoid Interferon

Randomized controlled trial of pegylated interferon-alfa 2a and ribavirin in treatment-naive chronic hepatitis C genotype 6

Hepatology ◽

10.1002/hep.23889 ◽

2010 ◽

Vol 52 (5) ◽

pp. 1573-1580 ◽

Cited By ~ 28

Author(s):

Khoa D. Lam ◽

Huy N. Trinh ◽

Son T. Do ◽

Thuan T. Nguyen ◽

Ruel T. Garcia ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Trial ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Randomized Controlled ◽

Treatment Naïve ◽

Pegylated Interferon Alfa-2b vs Standard Interferon Alfa-2b, Plus Ribavirin, for Chronic Hepatitis C in HIV-Infected PatientsA Randomized Controlled Trial

JAMA ◽

10.1001/jama.292.23.2839 ◽

2004 ◽

Vol 292 (23) ◽

pp. 2839 ◽

Cited By ~ 600

Author(s):

Fabrice Carrat

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Trial ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Standard Interferon ◽

Randomized Controlled ◽

Faculty Opinions recommendation of Randomized controlled trial of pegylated interferon-alfa 2a and ribavirin in treatment-naive chronic hepatitis C genotype 6.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.6210956.6276054 ◽

2011 ◽

Author(s):

William Lee ◽

He-Jun Yuan

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Trial ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Randomized Controlled ◽

Treatment Naïve ◽

Treatment of Chronic Hepatitis due to Hepatitis C Virus (CH-C) in India: A Randomized Controlled Trial Comparing Daily Interferon-alfa-2b and Ribavirin with Daily Interferon-alfa-2b and Glycyrrhizin—A Multicenter Study

Journal of Clinical and Experimental Hepatology ◽

10.1016/s0973-6883(12)60079-6 ◽

2012 ◽

Vol 2 (1) ◽

pp. 10-18 ◽

Cited By ~ 5

Author(s):

Subrat K Acharya ◽

V Sreenivas ◽

Siddharth Datta Gupta ◽

Shakti Kumar ◽

Yogesh K Chawla ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Multicenter Study ◽

Controlled Trial ◽

Interferon Alfa ◽

Retreatment with pegylated interferon alfa-2B plus ribavirin with or without amantadine of patients with chronic hepatitis C relapsing after standard interferon and ribavirin: Results of a randomized controlled trial

Digestive and Liver Disease ◽

10.1016/s1590-8658(06)80279-3 ◽

2006 ◽

Vol 38 ◽

pp. S104-S105

Author(s):

A. Ciancio ◽

C. Giordanino ◽

A. Smedile ◽

M. Tabone ◽

S. Martini ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Trial ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Standard Interferon ◽

Randomized Controlled ◽

Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: Results of a randomized, controlled trial

Hepatology ◽

10.1002/hep.510280208 ◽

1998 ◽

Vol 28 (2) ◽

pp. 341-346 ◽

Cited By ~ 36

Author(s):

Raffaello Sostegni ◽

Valeria Ghisetti ◽

Fabrizia Pittaluga ◽

Giovanna Marchiaro ◽

Giuseppe Rocca ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Trial ◽

Concomitant Administration ◽

Interferon Alfa ◽

Daily Versus Thrice-Weekly Interferon Alfa-2b Plus Ribavirin for the Treatment of Chronic Hepatitis C in HIV-Infected Persons: A Multicenter Randomized Controlled Trial

JAIDS Journal of Acquired Immune Deficiency Syndromes ◽

10.1097/00126334-200404150-00004 ◽

2004 ◽

Vol 35 (5) ◽

pp. 464-472 ◽

Cited By ~ 16

Author(s):

Mark S. Sulkowski ◽

Franco Felizarta ◽

Cheryl Smith ◽

Jidah Slim ◽

Ruth Berggren ◽

...

Keyword(s):

Multicenter Randomized Controlled Trial

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Trial ◽

Interferon Alfa ◽

Randomized Controlled ◽

Randomized, controlled trial including an initial 4-week daily "induction" period during one year of high-dose interferon alfa-2b treatment for chronic hepatitis C

Gastroenterology ◽

10.1016/s0016-5085(00)85984-3 ◽

2000 ◽

Vol 118 (4) ◽

pp. A960

Author(s):

Hernando J. Gonzales ◽

Samuel B. Ho ◽

John B. Gross ◽

Terry Therneau ◽

Craig J. Peine ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Induction Period ◽

Controlled Trial ◽

Interferon Alfa ◽

High Dose ◽

Randomized Controlled ◽

One Year ◽

High Dose Interferon